InvestorsHub Logo
Followers 0
Posts 718
Boards Moderated 0
Alias Born 12/08/2009

Re: dcspka post# 20915

Saturday, 04/19/2014 2:37:02 PM

Saturday, April 19, 2014 2:37:02 PM

Post# of 30046
dcspka, that contradicts vester_guy who has said MANY times that the "takeover group" already owns more than 55% of RXPC and is just waiting for patent news to announce the takeover.

LC Sentinel WAS onko-sure, by the way. That's all it was -- just another name for DR-70. Gartner took it with him when he left Provista -- today, Provista says very firmly in their correspondence that they are NOT using DR-70 in any of their tests and have no plans to do so, ever. Please contact them and ask yourself.

Finally -- there is no LC Sentinel today -- Gartner is trying to change its name to "the Lung Cancer Test."

Furthermore, onko-sure does not currently have FDA clearance for ANY purpose. So how will "they" use this test for lung cancer? Notice that GCDx has never actually tried to sell the test yet?

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.